GPX4 inhibitor RSL3 selectively reduced the residual persistent cell pool in several types of cancer cell lines including melanoma (A375 cell line), breast (BT474 cell line), lung (PC9 cell line) and ovarian (Kuramochi) cancer cells as well as in A375 melanoma cell lines-derived xenograft models119. The gene discussed is GPX4; the disease is cancer.